These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36263328)

  • 21. [A new method for adult height prediction in girls with idiopathic central precocious puberty treated with gonadotropin releasing hormone agonist].
    Liang Y; Wei H; Yu X; Song N; Luo X
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):840-4. PubMed ID: 26758323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near final height after GnRH agonist treatment in central precocious puberty.
    Micillo M; Salerno M; Officioso A; Perna E; Gasparini N; Pisaturo L; Di Maio S
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():787-90. PubMed ID: 10969922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D; Karavani G; Hirsch HJ; Strich D
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere length is not altered in girls with idiopathic central precocious puberty treated with a GnRH analog - leuprolide acetate.
    Furtado CLM; Iannetta R; Ferriani RA; Rosa E Silva ACJS; Martinelli CE; Calado RT; Dos Reis RM
    Gynecol Endocrinol; 2020 Dec; 36(12):1119-1123. PubMed ID: 32496827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I; Segni M; Ortore M; Arcadi E; Pasquino AM
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
    Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
    J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
    Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
    Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls.
    Shi Y; Ma Z; Yang X; Ying Y; Luo X; Hou L
    Front Endocrinol (Lausanne); 2022; 13():1085385. PubMed ID: 36589818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents.
    Ciancia S; Klink D; Craen M; Cools M
    Eur J Endocrinol; 2023 Sep; 189(3):396-401. PubMed ID: 37703317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Height benefit of GnRH agonists after age 8 in a Portuguese cohort of central precocious puberty.
    Castro C; Espada F; Leite AL; Antunes A; Robalo B; Amaral D; Galo E; Castro S; Ferreira S; Limbert C
    Clin Endocrinol (Oxf); 2023 May; 98(5):670-677. PubMed ID: 36710456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?
    Vuralli D; Gonc NE; Ozon ZA; Kandemir N; Alikasifoglu A
    Clin Endocrinol (Oxf); 2021 May; 94(5):804-810. PubMed ID: 33460480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body mass index in girls with idiopathic central precocious puberty during and after treatment with GnRH analogues.
    Arcari AJ; Gryngarten MG; Freire AV; Ballerini MG; Ropelato MG; Bergadá I; Escobar ME
    Int J Pediatr Endocrinol; 2016; 2016():15. PubMed ID: 27499763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of GnRH analog treatment on BMI in children treated for precocious puberty: a systematic review and meta-analysis.
    Zhu X; Qin J; Xue W; Li S; Zhao M; Yingliang Jin
    J Pediatr Endocrinol Metab; 2024 Apr; 37(4):297-308. PubMed ID: 38407229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty.
    Tseng CH; Lee YJ; Huang CY; Wu YL; Wang LT; Lin CH; Cheng BW; Lo FS; Chang YJ; Ting WH
    Front Endocrinol (Lausanne); 2023; 14():1271395. PubMed ID: 38027198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height.
    Kempers MJ; Otten BJ
    Eur J Endocrinol; 2002 Nov; 147(5):609-16. PubMed ID: 12444892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.